DAB method transfer for potency of cannabinoids in dry cannabis flower
-
Published:2022
Issue:02
Volume:68
Page:27-34
-
ISSN:1857-8969
-
Container-title:Macedonian Pharmaceutical Bulletin
-
language:en
-
Short-container-title:Maced. Pharm. Bull.
Author:
Cvetkovikj Karanfilova Ivana1, Stoilkovska Gjorgievska Veronika1, Stefkov Gjoshe1, Karapandzova Marija1, Trajkovska Ana1, Davkova Iskra2, Acevska Jelena3, Kulevanova Svetlana1, Brezovska Katerina3
Affiliation:
1. Instiute of Pharmacognosy, Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Mother Theresa 47, 1000 Skopje, Republic of North Macedonia 2. Center for Natural Products, Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Mother Theresa 47, 1000 Skopje, Republic of North Macedonia 3. Institute of Applied Chemistry and Pharmaceutical Analysis, Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy,Skopje, R. North Macedonia
Abstract
Cannabis is considered as heterogeneous matrix that contains complex profile of secondary metabolites, where more than 100 are classified as phytocannabinoids, present with an uneven distribution. In order to ensure its quality, application of suitable sample preparation techniques as well as time- and cost-efficient analytical methods is required. The DAB method depicts the obligatory procedure for potency testing of cannabinoids in cannabis flower in the EU. In this study we have performed method transfer in order to confirm the applicability of the method in determination of varying quantities of cannabioniods in different cannabis strains, focusing on samples with low content of CBD or THC or samples where one of these two cannabiniods is not detected. The HPLC-DAD method was validated and used for routine control of the content and consistency of medical cannabis. Limits of detection, limits of quantitation, accuracy, precision, and intermediate precision were found to be highly satisfactory.
Keywords: HPLC assay, CBD, THC, CBN, CBDA, THCA, method validation, DAB, quality control
Publisher
Macedonian Pharmaceutical Association
Reference15 articles.
1. Citti, C., Russo, F., Sgrò, S., Gallo, A., Zanotto, A., Forni, F., Vandelli, M.A., Laganà, A., Montone, C.M., Gigli, G., Cannazza, G., 2020. Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence. Anal. Bioanal. Chem. 412, 4009-4022. Available at: https://doi.org/10.1007/s00216-020-02554-3 2. Council of Europe. Cannabis flos Monograph N◦: 3028. In European Pharmacopoeia, 10th ed.; Council of Europe: Strasbourg, France, 2023. 3. De Backer, B., Debrus, B., Lebrun, P., Theunis, L., Dubois, N., Decock, L., Verstraete, A., Hubert, P., Charlier, C., 2009. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material. J. Chromatogr. B. 877, 4115-4124. Available at: https://doi.org/10.1016/j.jchromb.2009.11.004 4. Geschäftsstelle der Arzneibuch-Kommissionen. Bundesinstitut fur Arzneimittel und Miedizinprodukte, Monografie Cannabis blüten. In German Pharmacopoeia, 2018th ed.; Geschäftsstelle der Arzneibuch-Kommissionen: Bundesinstitut fur Arzneimittel und Miedizinprodukte: Bonn, German, 2018. 5. International Organization for Standardization, 2018. EN ISO / IEC 17025:2018 General requirements for the competence of testing and calibration laboratories. (order number 3681. from 03.07.2019).
|
|